ClinicalTrials.gg
RecruitingNCT06681077Updated Nov 10, 2026

A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New York

An interventional study of Community Health Education and Telephone Based Intervention in Healthy, sponsored by Roswell Park Cancer Institute. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Roswell Park Cancer Institute · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.
Updated Nov 10, 2026Interventions changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This clinical trial evaluates a community health education intervention (I CAN) for increasing community-driven actions to reduce the cancer burden in Western New York. Engaging community members is a critical component of designing impactful programs to reduce the cancer burden. Leaders at the national, state, and local levels have all called for more community partnerships and engagement in design of health intervention and policies. The I CAN intervention is a workshop that includes a presentation outlining key concepts related to social network processes and the cancer burden in Western New York, a structured skill-building activity, and then empowering and motivating activities meant to cultivate momentum and excitement for action. This community health education intervention may be able to provide a formalized process for empowering and facilitating community members to take steps to reduce the community cancer burden.

Read the detailed description

PRIMARY OBJECTIVES:

Phase I - Feasibility and Acceptability - 100 participants to be enrolled

  • Examine the feasibility of the I CAN intervention. (Phase I)
  • Examine the acceptability of the I CAN intervention. (Phase I)
  • Examine topic areas selected for action within participants' I CAN plans for action. (Phase I)

Phase II - Effectiveness of intervention trial for Lung Cancer Screening - 400 participants to be enrolled

  • Determine whether the I CAN intervention will result in higher number of individuals who complete lung cancer screening compared to didactic educational control. (Phase 2 [Effectiveness of intervention trial for lung cancer screening])
  • Evaluate whether the I CAN intervention improves adherence to recommended annual lung cancer screening follow-up among participants who initially received low dose computed tomography of the chest (LDCT) screening. (Phase 2 [Effectiveness of intervention trial for lung cancer screening])
  • Assess whether the I CAN intervention results in different levels of lung cancer screening knowledge and self-efficacy compared to the control group. (Phase 2 [Effectiveness of intervention trial for lung cancer screening])

OUTLINE:

Participants are assigned to 1 of 2 phases. Phase I - Participants attend an I CAN intervention workshop over 2 hours. Phase 2 - Community-based programs are randomized to 1 of 2 arms and participants are assigned to the arm to which their community-based program was randomized.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

Roswell Park Cancer Institute is the lead sponsor of 419 studies on the registry; 65 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 21 (55%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being over 18 years old
  • Able to participate in English

Exclusion criteria

Exclusion Criteria:

  • Unwilling or unable to follow protocol requirements
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
Double (Participant, Investigator)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Prevention (I CAN intervention) - Phase 1

    Participants attend an I CAN intervention workshop over 2 hours.

    Procedure: Community Health Education

  • Experimental
    I CAN Intervention - Phase 2

    Participants attend an I CAN intervention workshop over 2 hours. Two weeks after I CAN intervention workshop, participants receive a coaching call to assess progress, challenges, and revisions to I CAN plan.

    Procedure: Community Health Education · Behavioral: Telephone Based Intervention

  • Active comparator
    Lung cancer screening Education Program - Phase 2

    Participants attend a didactic lung cancer screening educational program over 45 minutes on study. Participants may also receive referrals to Roswell Park cancer screening navigators as well as navigator follow up as needed on study

    Behavioral: Telephone Based Intervention · Other: Educational Intervention

Interventions

  • ProcedureCommunity Health Education

    Receive I CAN intervention

    Also known as: Community Education

  • BehavioralTelephone Based Intervention

    Receive coaching call

  • OtherEducational Intervention

    Attend lung cancer screening educational program

06

What researchers measure

Primary outcomes

  1. Demand - Phase 1

    Feasibility will be assessed through demand, which will be evaluated as the number of people enrolled and the demographics of participants. Descriptive analyses will be used.

    Time frame: Up to 2 years

  2. Practicality - Phase 1

    Practicality will be assessed through the percentage of participants who complete different aspects of the intervention. Descriptive analyses will be used.

    Time frame: Up to 2 years

  3. Acceptability- Phase 1

    Acceptability will be examined through post-intervention measures, including the Acceptability of Intervention Measure, Intervention Appropriateness Measure, and Feasibility of Intervention Measure. Descriptive analyses will be used.

    Time frame: Up to 2 years

  4. Lung Cancer Screening Uptake

    Will be assessed by determining if I CAN intervention results in higher number of individuals who complete lung cancer screening

    Time frame: Up to 2 years

Secondary outcomes

  1. Rate of follow up for Lung cancer screening

    Time frame: 6 months post screening (estimated to be 2 years)

Other outcomes

  1. Lung Cancer Screening knowledge - Phase 2

    Will be compared between arms using an 8 item survey of True/False questions

    Time frame: initial assessment and 6 months post screening (estimated to be up to 2 years)

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2024 (actual). Primary completion is estimated for Nov 2028, 47 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 1, 2024
First posted
Nov 8, 2024
StartActual
Nov 16, 2024
Primary completionEst.
Nov 15, 2028
CompletionEst.
Nov 15, 2028
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Interventions
Added Educational Intervention. Arms added: Lung cancer screening Education Program - Phase 2
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Interventions Added Educational Intervention. Arms added: Lung cancer screening Education Program - Phase 2
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06681077
Collaborators
Merck Sharp & Dohme LLC, National Comprehensive Cancer Network
Responsible party
Sponsor
First posted
Nov 8, 2024
Start date
Nov 16, 2024
Primary completion
Nov 15, 2028 (estimated)
Completion
Nov 15, 2028 (estimated)
Last update
Nov 10, 2026

Study contacts

Elizabeth Bouchard
principal investigator · Roswell Park Cancer Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion